Tenaya Therapeutics (TNYA) Other Gross PP&E Adjustments (2020 - 2026)

Tenaya Therapeutics' Other Gross PP&E Adjustments history runs 7 years deep, the most recent figure standing at $58.8 million for Q1 2026.

• In Q1 2026, Other Gross PP&E Adjustments rose 3.96% year-over-year to $58.8 million; the TTM figure through Mar 2026 stood at $58.8 million (up 3.96% YoY), while the FY2025 annual figure was $57.5 million, up 2.94% from the prior year.
• Other Gross PP&E Adjustments was $58.8 million for Q1 2026 at Tenaya Therapeutics, up from $57.5 million in the prior quarter.
• In the past five years, Other Gross PP&E Adjustments ranged from a high of $58.8 million in Q1 2026 to a low of $47.9 million in Q1 2022.
• Historically, Other Gross PP&E Adjustments has averaged $55.5 million across 5 years, with a median of $56.4 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Gross PP&E Adjustments surged 153.63% in 2022, then decreased 4.4% in 2024.
• A 5-year view of Other Gross PP&E Adjustments shows it stood at $54.6 million in 2022, then grew by 4.27% to $56.9 million in 2023, then fell by 1.88% to $55.8 million in 2024, then gained by 2.94% to $57.5 million in 2025, then advanced by 2.37% to $58.8 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at $58.8 million (Q1 2026), $57.5 million (Q4 2025), and $57.9 million (Q3 2025), per Business Quant data.